DK2272507T3 - Transdermalt præparat omfattende et opioidanalgetikum og en aloesammensætning - Google Patents

Transdermalt præparat omfattende et opioidanalgetikum og en aloesammensætning

Info

Publication number
DK2272507T3
DK2272507T3 DK10012336.3T DK10012336T DK2272507T3 DK 2272507 T3 DK2272507 T3 DK 2272507T3 DK 10012336 T DK10012336 T DK 10012336T DK 2272507 T3 DK2272507 T3 DK 2272507T3
Authority
DK
Denmark
Prior art keywords
composition
aloe
opioid analgesic
transdermal
transdermal composition
Prior art date
Application number
DK10012336.3T
Other languages
English (en)
Inventor
Elisabeth Meyer
Peter Altenschoepfer
Angelika Baumann
Sarah Mcleod
Original Assignee
Acino Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34202336&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2272507(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Acino Ag filed Critical Acino Ag
Application granted granted Critical
Publication of DK2272507T3 publication Critical patent/DK2272507T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK10012336.3T 2003-09-02 2004-07-26 Transdermalt præparat omfattende et opioidanalgetikum og en aloesammensætning DK2272507T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10340428.7A DE10340428B4 (de) 2003-09-02 2003-09-02 Opioides Analgetikum enthaltende transdermale Formulierung
EP04763497A EP1660055B1 (en) 2003-09-02 2004-07-26 Transdermal formulation comprising an opioid analgesic and an aloe composition

Publications (1)

Publication Number Publication Date
DK2272507T3 true DK2272507T3 (da) 2012-12-17

Family

ID=34202336

Family Applications (2)

Application Number Title Priority Date Filing Date
DK04763497.7T DK1660055T3 (da) 2003-09-02 2004-07-26 Transdermalt præparat omfattende et opioidanalgetikum og en aloesammensætning
DK10012336.3T DK2272507T3 (da) 2003-09-02 2004-07-26 Transdermalt præparat omfattende et opioidanalgetikum og en aloesammensætning

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK04763497.7T DK1660055T3 (da) 2003-09-02 2004-07-26 Transdermalt præparat omfattende et opioidanalgetikum og en aloesammensætning

Country Status (10)

Country Link
US (1) US20070077284A1 (da)
EP (2) EP1660055B1 (da)
JP (2) JP5244313B2 (da)
CA (1) CA2534338C (da)
DE (1) DE10340428B4 (da)
DK (2) DK1660055T3 (da)
ES (2) ES2394311T3 (da)
PL (2) PL1660055T3 (da)
PT (2) PT2272507E (da)
WO (1) WO2005020966A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007021549A1 (de) 2007-05-08 2008-11-13 Novosis Ag Transdermales therapeutisches System enthaltend mindestens zwei Opioide
WO2009000262A1 (de) * 2007-06-25 2008-12-31 Acino Ag Elektrophoretisches transdermales applikationssystem
EP2366388A1 (de) 2010-03-17 2011-09-21 Ratiopharm GmbH Nicht-okklusives transdermales therapeutisches System zur Verabreichung von Buprenorphin
WO2015025767A1 (ja) * 2013-08-21 2015-02-26 久光製薬株式会社 貼付剤
DE102014013448A1 (de) 2014-09-16 2016-03-17 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales Therapeutisches System umfassend Buprenorphin
US9656441B2 (en) 2015-01-08 2017-05-23 Alfred E. Tiefenbacher ( Gmbh & Co. Kg) Transdermal patch
JP6879734B2 (ja) * 2016-12-27 2021-06-02 小林製薬株式会社 皮膚浸透促進剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4336243A (en) 1980-08-11 1982-06-22 G. D. Searle & Co. Transdermal nitroglycerin pad
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4751087A (en) 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
US4615699A (en) 1985-05-03 1986-10-07 Alza Corporation Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
SK130298A3 (en) * 1996-03-25 1999-03-12 Lohmann Therapie Syst Lts Transdermal therapeutic system with small application-area thickness and great flexibility, and production process
ATE224211T1 (de) * 1996-07-10 2002-10-15 Coloplast As Klebstoffezubereitung und deren verwendung
US5900420A (en) * 1997-06-19 1999-05-04 Cole; William L. Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine
US6946144B1 (en) * 1998-07-08 2005-09-20 Oryxe Transdermal delivery system
PT1102589E (pt) * 1998-07-16 2006-12-29 Memorial Sloan Kettering Inst Composições tópicas compreendendo um analgésico opióide e um antagonista do nmda
US6455066B1 (en) * 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
US7029694B2 (en) * 2000-04-26 2006-04-18 Watson Laboratories, Inc. Compositions and methods for transdermal oxybutynin therapy
US7125884B2 (en) * 2001-03-02 2006-10-24 Euro-Celtique S.A. N-but-3-enyl norbuprenorphine and its use as analgesic
US20040001882A1 (en) * 2002-03-06 2004-01-01 Hexal Ag Transdermal system with fentanyl
ATE394097T1 (de) * 2002-03-20 2008-05-15 Euro Celtique Sa Verfahren zur verabreichung von buprenorphin zur behandlung von depression
WO2007134434A1 (en) * 2006-05-18 2007-11-29 Merck Frosst Canada Ltd. Phenanthrene derivatives as mpges-1 inhibitors

Also Published As

Publication number Publication date
EP2272507A1 (en) 2011-01-12
DK1660055T3 (da) 2012-12-17
JP2012188447A (ja) 2012-10-04
EP2272507B1 (en) 2012-10-10
JP5789563B2 (ja) 2015-10-07
EP1660055A1 (en) 2006-05-31
PL1660055T3 (pl) 2013-03-29
WO2005020966A1 (en) 2005-03-10
EP1660055B1 (en) 2012-10-24
PL2272507T3 (pl) 2013-03-29
JP2007504183A (ja) 2007-03-01
DE10340428A1 (de) 2005-03-24
ES2394311T3 (es) 2013-01-30
JP5244313B2 (ja) 2013-07-24
DE10340428B4 (de) 2015-02-12
PT1660055E (pt) 2012-12-21
US20070077284A1 (en) 2007-04-05
PT2272507E (pt) 2013-01-14
CA2534338C (en) 2012-12-04
ES2394313T3 (es) 2013-01-30
CA2534338A1 (en) 2005-03-10

Similar Documents

Publication Publication Date Title
DK1592686T3 (da) Gyrase-inhibitorer og anvendelser deraf
ATE423121T1 (de) Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren
NO20040640L (no) Anordning og fremgangsmate
NO20054453D0 (no) P38 inhibitorer og fremgangsmater for anvendelse derav
DK2719368T3 (da) Lægemiddeldispenser og anordning derfor
DK1519770T3 (da) Elektroporesisk indretning og indsprøjtningsapparat
DK1765793T3 (da) Anacetrapib og andre cetp-inhibitorer
DK2302055T3 (da) Fremgangsmåder og sammensætninger involverende miRNA og miRNA-inhibitormolekyler
ATE521604T1 (de) N-substituierte benzimidazolyl-c-kit-inhibitoren und kombinatorische benzimidazolbibliothek
DK1997809T3 (da) P38-inhibitorer og fremgangsmåder til anvendelse deraf
DK1891973T3 (da) Kombinationer omfattende antimuskarine midler og PDE4-hæmmere
IS8329A (is) Kínólínafleiður og notkun þeirra í meðferð
DK1715893T3 (da) Direkte kompressionsformulering og fremgangsmåde
EP1613254A4 (en) TRANSDERMAL ANALGESIC COMPOSITION AND METHODS OF MAKING AND USING THE SAME
DE602004023915D1 (de) Selbsterkennungsverfahren und -vorrichtung
DE602004011604D1 (de) Informationsendgerät und Inhaltssicherungsmethode
FI20020757A0 (fi) Suihkutusmenetelmä ja -laitteisto
DE602005010059D1 (de) Gehäuse und betätigungsvorrichtung sowie zugehörige verfahren
HK1100927A1 (en) Substituted quinolines and their use as mycobacterial inhibitors
DE602004012417D1 (de) Dekodierungsvorrichtung und dekodierungsverfahren
DK1882054T3 (da) Korrosionsbeskyttelsesanordning og fremgangsmåde
DK1660055T3 (da) Transdermalt præparat omfattende et opioidanalgetikum og en aloesammensætning
NO20044269L (no) Smamolekylaere inntrengningsinhibitorer
NO20055668D0 (no) Beta-amyloidinhibitorer og anvendelse derav
EP1583528A4 (en) NF-KB INHIBITORS AND ITS USES